Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study
Crossref DOI link: https://doi.org/10.1007/s12325-014-0161-5
Published Online: 2014-11-01
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Donck, Jan
Gonzalez-Tabares, Lourdes
Chanliau, Jacques
Martin, Heike
Stamatelou, Kyriaki
Manamley, Nick
Farouk, Mourad
Addison, Janet